Copper-67 Radioimmunotherapy and Growth Inhibition by Anti–L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis
Authors:
Open Access
- 15 January 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (2) , 603-611
Abstract
Purpose: We examined the tumor-targeting and therapeutic effects of 67Cu-labeled single amino acid mutant forms of anti-L1 monoclonal antibody chCE7 in nude mice with orthotopically implanted SKOV3ip human ovarian carcinoma cells.Keywords
This publication has 35 references indexed in Scilit:
- Phase III Trial of Intraperitoneal Therapy With Yttrium-90–Labeled HMFG1 Murine Monoclonal Antibody in Patients With Epithelial Ovarian Cancer After a Surgically Defined Complete RemissionJournal of Clinical Oncology, 2006
- Tailoring antibodies for radionuclide deliveryExpert Opinion on Drug Delivery, 2005
- Epidermal Growth Factor Receptor Inhibitors: A Moving Target?Clinical Cancer Research, 2005
- Intraperitoneal Radioimmunotherapy with a Humanized Anti-TAG-72 (CC49) Antibody with a Deleted CH2 RegionCancer Biotherapy and Radiopharmaceuticals, 2005
- Success of Bevacizumab Trials Raises Questions for Future StudiesJNCI: Journal of the National Cancer Institute, 2005
- Treatment of Non-Hodgkin’s Lymphoma (NHL) With Radiolabeled Antibodies (mAbs)Seminars in Nuclear Medicine, 2005
- Activity of bevacizumab (rhuMAB VEGF) in advanced refractory epithelial ovarian cancerGynecologic Oncology, 2005
- Hepatocyte Growth Factor-induced Ectodomain Shedding of Cell Adhesion Molecule L1Journal of Biological Chemistry, 2004
- Extracellular Signal-regulated Kinase (ERK)-dependent Gene Expression Contributes to L1 Cell Adhesion Molecule-dependent Motility and InvasionJournal of Biological Chemistry, 2004
- Internalization and degradation of monoclonal antibody chCE7 by human neuroblastoma cellsInternational Journal of Cancer, 1994